RUMOF yields 3.87% · JNJ yields 2.13%● Live data
📍 RUMOF pulled ahead of the other in Year 1
Combined, RUMOF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of RUMOF + JNJ for your $10,000?
Rumo S.A., through its subsidiaries, provides rail transportation services. The company operates through four segments: Northern Operations, South Operations, Central Operations, and Container Operations. It offers logistics services primarily for exporting commodities, including integrated solution for transportation, handling, storage, and shipping from the production centers to the principal ports in the south and southeast of Brazil; and railway, highway, transshipment, and port elevation operations. The company transports agricultural commodities, including fertilizers, corn, wheat, soy, bran, vegetable oil, and sugar; and fuel, construction, steel, forestry, consumption, petrochemical, and container products. It is also involved in the provision of terminal and storage services; and container logistics services for various cargo, including meats, wood, and other consumer goods. The company was formerly known as ALL América Latina Logística S.A. Rumo S.A. was founded in 1997 and is headquartered in Curitiba, Brazil.
Full RUMOF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.